Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
Opportunistic infections are preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis.
Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.
Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study.
ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry.
Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study.
Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis